Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Transoma's Sleuth ECG monitor:

This article was originally published in Clinica

Executive Summary

Transoma Medical has gained US 510(k) clearance for its Sleuth electrocardiogram monitoring system. The St Paul, Minnesota firm claims it is the first wireless, implantable heart monitor for humans. The Sleuth provides data to aid the diagnosis of cardiac arrhythmias and other conditions that can cause unexplained fainting. Patients who feel faint can press a symptom button to activate the device for the duration of the fainting spell. The system also automatically captures ECG data when the patient's heart rate is above or below programmed limits. In the US, sudden fainting accounts for 6% of hospital admissions, and is caused by a cardiovascular condition in 90% of these patients.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049893

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel